Sahak, Judith C.

HRN: 07-33-15  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
CEFUROXIME 1.5GM (VIAL)
06/27/2022
07/04/2022
IV
1.5g
Q8
Recurrent UTI
06/30/2022
METRONIDAZOLE 500MG (TAB)
06/30/2022
07/06/2022
ORAL
500mg
TID
SE: E.histolytica Cyst, Ascaris, T.trichuria
Waiting Final Action 
06/30/2022
MEBENDAZOLE 50MG/ML, 60ML SUSPENSION (BOT)
06/30/2022
07/06/2022
ORAL
5ml
BID
SE: Ascaris, T.trichiura
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: